v3.25.3
Share-Based Payments - Share-Based Compensation Expense Included In Statements Of Income (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-based Compensation Expense included in consolidated statements of income        
Subtotal $ 78.4 $ 131.1 $ 240.6 $ 275.4
Capitalized share-based compensation costs (3.1) (2.4) (9.4) (8.0)
Share-based compensation expense included in total cost and expense 75.3 128.7 231.2 267.4
Income tax effect (14.4) (24.2) (45.3) (50.5)
Research and development        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense 28.8 69.8 91.0 124.5
Selling, general and administrative        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense 49.6 61.3 149.6 150.9
Share-based compensation expense included in net income attributable to Biogen Inc.        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense $ 60.9 $ 104.5 $ 185.9 $ 216.9